|Executive summary: heart disease and stroke statistics—2013 update: a report from the American Heart Association|
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, WB Borden, ...
Circulation 127 (1), 143-152, 2013
|Heart disease and stroke statistics-2016 update a report from the American Heart Association|
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...
Circulation 133 (4), e38-e48, 2016
|Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and …|
SC Palmer, A Hayen, P Macaskill, F Pellegrini, JC Craig, GJ Elder, ...
Jama 305 (11), 1119-1127, 2011
|Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials|
GFM Strippoli, SD Navaneethan, DW Johnson, V Perkovic, F Pellegrini, ...
Bmj 336 (7645), 645-651, 2008
|Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials|
G De Berardis, M Sacco, GFM Strippoli, F Pellegrini, G Graziano, ...
Bmj 339, b4531, 2009
|Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review|
GFM Strippoli, M Craig, JJ Deeks, FP Schena, JC Craig
Bmj 329 (7470), 828, 2004
|Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials|
EM Hodson, CA Jones, AC Webster, GFM Strippoli, PG Barclay, K Kable, ...
The Lancet 365 (9477), 2105-2115, 2005
|Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease|
SC Palmer, SD Navaneethan, JC Craig, DW Johnson, M Tonelli, AX Garg, ...
Annals of internal medicine 153 (1), 23-33, 2010
|Associations between hemodialysis access type and clinical outcomes: a systematic review|
P Ravani, SC Palmer, MJ Oliver, RR Quinn, JM MacRae, DJ Tai, ...
Journal of the American Society of Nephrology 24 (3), 465-473, 2013
|Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review|
M Franciosi, G Lucisano, E Lapice, GFM Strippoli, F Pellegrini, A Nicolucci
PloS one 8 (8), e71583, 2013
|Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients|
EM Hodson, M Ladhani, AC Webster, GFM Strippoli, JC Craig
Cochrane database of systematic reviews, 2013
|Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy|
C Manno, GFM Strippoli, L Arnesano, C Bonifati, N Campobasso, ...
Kidney international 66 (4), 1570-1577, 2004
|Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies|
S Palmer, M Vecchio, JC Craig, M Tonelli, DW Johnson, A Nicolucci, ...
Kidney international 84 (1), 179-191, 2013
|The number, quality, and coverage of randomized controlled trials in nephrology|
GFM Strippoli, JC Craig, FP Schena
Journal of the American Society of Nephrology 15 (2), 411-419, 2004
|Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis|
SC Palmer, JC Craig, SD Navaneethan, M Tonelli, F Pellegrini, ...
Annals of internal medicine 157 (4), 263-275, 2012
|Meta-analysis: vitamin D compounds in chronic kidney disease|
SC Palmer, DO McGregor, P Macaskill, JC Craig, GJ Elder, GFM Strippoli
Annals of internal medicine 147 (12), 840-853, 2007
|Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials|
RS Flanc, MA Roberts, GFM Strippoli, SJ Chadban, PG Kerr, RC Atkins
American Journal of Kidney Diseases 43 (2), 197-208, 2004
|Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis|
SD Navaneethan, SU Nigwekar, AR Sehgal, GFM Strippoli
Clinical Journal of the American Society of Nephrology 4 (3), 542-551, 2009
|Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease|
GFM Strippoli, C Bonifati, ME Craig, SD Navaneethan, JC Craig
Cochrane Database of Systematic Reviews, 2006
|Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis|
SC Palmer, D Mavridis, E Navarese, JC Craig, M Tonelli, G Salanti, ...
The Lancet 385 (9982), 2047-2056, 2015